Physician profile
Mark Andrew Stid
NPI 1740243369
$1,275.74
in general payments reported to CMS, 2019-2025
21 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Hospice and Palliative Medicine (Family Medicine) provider received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $67.87 · 2021: $15.25 · 2022: $55.71 · 2023: $168 · 2024: $69.92 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $368.61 | 2019-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $314.25 | 2019-2025 | Farxiga, Breztri |
| Amgen INC. | $74.73 | 2019 | |
| Pfizer INC. | $62.27 | 2019 | |
| Glaxosmithkline, LLC. | $58.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.41 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $42.29 | 2019-2023 | Eliquis, Camzyos |
| Teva Pharmaceuticals USA, INC. | $38.28 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.58 | 2019 | |
| Lilly USA, LLC | $23.85 | 2019 | |
| Dexcom, INC. | $19.70 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.10 | 2019 | |
| Alfasigma USA, INC. | $16.63 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.48 | 2019 | |
| Shire North American Group INC | $15.39 | 2019 | |
| Amarin Pharma, INC. | $14.94 | 2020 | |
| Horizon Therapeutics Plc | $13.20 | 2019 | |
| Allergan, INC. | $13.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Stid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.